Sclerotherapy is commonly used approach to treat small, medium and larger varicose veins. Recently, Varithena treatment, which is a specialized foam sclerotherapy solution, was approved by the FDA for use in the US. This is a specialty formulated foam sclerotherapy that retains its confirmation for a longer time, and therefore is more effective at closing the varicose veins.
In this procedure, a catheter is placed on the inside of the vein, and foam bubbles are injected under ultrasound guidance by the doctor, which causes the veins to spasm, and close off. This approach is especially best suited for patients with complicated varicose veins, such as those patients who have had prior clots in the veins, making passage of a catheter up the vein more difficult.
The Varithena Treatment Data:
The use of Varithena as a treatment for varicose veins was evaluated in multiple clinical trials where it was shown to be safe and effective. In addition, it was evaluated in the VANISH II trial where it was shown to be versitile for a wide variety of varicose vein conditions.
We treat patients with Varithena at our Inovia® Vein Specialty Centers. We are currently scheduling patients in our clinic at The Center next to St. Charles Medical Center (which serves Oregon patients from Bend, Redmond, Prineville, Madras, La Pine, Baker City, Burns, and John Day) and scheduling patients for our clinic at the Bridgeport Village Center in Tigard, Oregon (for Oregon patients from Portland, Tigard, Lake Oswego, West Linn, Hillsboro, Beaverton, Sherwood, Tualatin, Wilsonville, Clackamas, Sunnyside, and Milwaukie).